Levitee Labs Inc. Stock News

Levitee Labs (CSE:LVT) Inc has announced the completion of the sale of the right, title and interest in all of the assets of Earth Circle Organics Chain Inc to B&W Acquisition Corp on August 29, 2022.

Levitee Labs (CSE:LVT) Inc has appointed economist David Bentil as chief executive officer and director following the resignation of Philip van den Berg as interim CEO and director. The integrative we

Levitee Labs (CSE:LVT) Inc announced the appointment of Philip van den Berg as the company's new interim CEO and director, effectively immediately, replacing Pouya Farmand who will be moving to the po

Levitee Labs (CSE:LVT) Inc, a wellness company with an established portfolio of cash-flowing wellness assets, has revealed that it is proposing to complete a non-brokered private placement of up to 15

Levitee Labs (CSE:LVT) Inc, a wellness company with an established portfolio of cash-flowing wellness assets, announced the execution of a distribution agreement with Body Energy Club, a top health su

Wellness company Levitee Labs Inc. (CSE:LVT) (OTC:LVTTF) (FSE:7H7) confirmed Monday that it has teamed up with cannabinoid company Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F).

Levitee Labs (CSE:LVT) Inc said it has entered into a strategic partnership via a service agreement with Canntab Therapeutics Limited to contribute towards correcting the opioid crisis in Canada.  Un

Levitee Labs (CSE:LVT) Inc announced that it has formed a medical advisory board consisting of experts across a diverse group of fields, including addiction, mental health, drug development, compoundi

Changing the landscape of mental health, pain management, and addiction Establishing a platform that will bridge traditional treatments with psychedelic applications Accretive M&A regimen securing pro

Levitee Labs (CSE:LVT) Inc announced that it is collaborating with the LiveRx Research Group for testing, treating, and curing Hepatitis C Virus (HCV) in Alberta, and providing equitable access to H

Levitee Labs (CSE:LVT) Inc has announced the appointment of Noha ElSayed as its executive director, Levitee Clinics and Levitee Pharmacies, Alberta Region. The company noted that ElSayed brings a weal

Levitee Labs (CSE:LVT) Inc announced it has signed a letter of intent (LOI) to acquire 100% of the issued and outstanding shares in a company owning and operating a chain of specialty addiction pharma

Levitee Labs (CSE:LVT) Inc said it generated a combined $1,553,728 in unaudited revenue during September 2021 and October 2021. The company said it has seen consistent growth across all its divisions,

Levitee Labs Inc (CSE:LVT) Inc announced that it has signed a letter of intent to acquire 51% of the issued and outstanding shares of Compounding Pharmacy — a new research and development pharmacy